PURPOSE: Doubtlessly modern high voltage radiation treatment has less side effects than former techniques. It may be better than conventional methods with respect to 5-year survival rates, but that has to be proven using a large number of cases. PATIENTS AND METHODS: Retrospective study using the material of one department of gynecology and obstetrics, practicing both operation and irradiation. 1830 cervical carcinomas are differentiated in stages and then divided in 3 historical collectives. From 1959 to 1968 there was a combination of traditional contact therapy with conventional X-ray irradiation. The period from 1969 to 1972 is characterized as a changing one with partly therapy as described above, partly traditional contact therapy was combined with biaxial telecobalt therapy. From 1973 to 1986 a reduced contact therapy doses was applied to pelvic high voltage irradiation. RESULTS: Five-year survival rate in stage I was 79% in conventional treatment and with ultra high energy 77%. The corresponding figures in stage II are 56% respectively 52%, in stage III 26% respectively 25% (Table 1) of gynecology and obstetrics, practicing both operation and irradiation. CONCLUSION: Application of ultra high energy radiation in higher doses in Rostock had not the consequence of elevating the 5-year survival rate, but the quality of life is much better.
PURPOSE: Doubtlessly modern high voltage radiation treatment has less side effects than former techniques. It may be better than conventional methods with respect to 5-year survival rates, but that has to be proven using a large number of cases. PATIENTS AND METHODS: Retrospective study using the material of one department of gynecology and obstetrics, practicing both operation and irradiation. 1830 cervical carcinomas are differentiated in stages and then divided in 3 historical collectives. From 1959 to 1968 there was a combination of traditional contact therapy with conventional X-ray irradiation. The period from 1969 to 1972 is characterized as a changing one with partly therapy as described above, partly traditional contact therapy was combined with biaxial telecobalt therapy. From 1973 to 1986 a reduced contact therapy doses was applied to pelvic high voltage irradiation. RESULTS: Five-year survival rate in stage I was 79% in conventional treatment and with ultra high energy 77%. The corresponding figures in stage II are 56% respectively 52%, in stage III 26% respectively 25% (Table 1) of gynecology and obstetrics, practicing both operation and irradiation. CONCLUSION: Application of ultra high energy radiation in higher doses in Rostock had not the consequence of elevating the 5-year survival rate, but the quality of life is much better.
Authors: M L Berman; L D Lagasse; W G Watring; S C Ballon; R E Schlesinger; J G Moore; R C Donaldson Journal: Obstet Gynecol Date: 1977-12 Impact factor: 7.661